Click a link below to view the mailing archive as if it had been sent to you.
| 2015-11-30 12:15 | | Report: Sanofi cooking up $12.7B animal health spinoff and more... |
| 2015-11-30 00:15 | | 4 Key FDA Decisions Expected By Year End and more... |
| 2015-11-28 00:15 | | FDA declines expanded approval for Bristol-Myers' Opdivo drug and more... |
| 2015-11-27 12:15 | | Novo Nordisk's First Diabetes Pill Could Be A $10-20 Billion Super-Blockbuster and more... |
| 2015-11-26 00:15 | | How Johnson & Johnson Spent $71 Billion in 12 Months and more... |
| 2015-11-25 12:15 | | First flu vaccine with immune-boosting adjuvant approved for US market and more... |
| 2015-11-25 00:15 | | The 'Pfallergan' fallout: Reactions to—and questions for—the biggest healthcare deal of all time and more... |
| 2015-11-24 12:15 | | Why Pfizer, Allergan Plunged Yesterday and more... |
| 2015-11-24 00:15 | | Cramer: Can Pfizer reinvent itself with Allergan? and more... |
| 2015-11-23 12:15 | | Bristol-Myers Lets Low-Income Countries Copy Hepatitis C Pills and more... |
| 2015-11-23 00:15 | | Pfizer set to buy Allergan for more than $150 billion and more... |
| 2015-11-22 12:15 | | Top Allergan investors concerned group could be sold too cheaply and more... |
| 2015-11-22 00:15 | | Pfizer, Allergan Could Merge By Monday; Street Dismisses Treasury Scare and more... |
| 2015-11-21 00:15 | | Novartis Admits To Valeant-like Pharmacy Scheme in $390 Million Settlement and more... |
| 2015-11-20 12:15 | | FDA staff unveils strongly critical review of BioMarin Duchenne drug ahead of crucial meeting and more... |
| 2015-11-20 00:15 | | Mallinckrodt boosts buyback plan amid news of a 2,000% price hike on infant drug and more... |
| 2015-11-19 12:15 | | Clovis Oncology's Loss Could Be a Win for AstraZeneca and more... |
| 2015-11-19 00:15 | | Pfizer-Allergan talks accelerate amid new inversion clamp-down and more... |
| 2015-11-18 12:15 | | Is Allergan-Amgen Merger Possible? and more... |
| 2015-11-18 00:15 | | Valeant faces new trouble as dermatologists sour on its drugs and more... |
| 2015-11-17 12:15 | | Is Mylan Preparing For An Acquisition? and more... |
| 2015-11-17 00:15 | | It's payers vs. pharma and vice versa as Washington targets drug prices and more... |
| 2015-11-16 12:15 | | In major victory, AstraZeneca wins FDA approval for potential $3B lung cancer med and more... |
| 2015-11-15 12:15 | | Juno Therapeutics Finishes Q3 in Good Shape Where It Matters Most and more... |
| 2015-11-14 12:15 | | AbbVie Announces New Data on VIEKIRA PAK® (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Patients with Chronic Hepatitis C Virus Infection With or Without Compensated Cirrhosis and more... |
| 2015-11-14 00:15 | | Drug makers beat diabetes lawsuits with an unusual ruling and more... |
| 2015-11-13 12:15 | | Rumors Suggest Valeant Played A Key Role In Operating Troubled Philidor and more... |
| 2015-11-13 00:15 | | U.S. appeals court invalidates four Merck Cubicin patents and more... |
| 2015-11-12 12:15 | | Philidor Finally Speaks Out On Valeant Pharmaceuticals Intl Inc Controversy and more... |
| 2015-11-12 00:15 | | Google Life Sciences teams with AHA to target heart disease in $50M research initiative and more... |
| 2015-11-11 12:15 | | Outer space: The final frontier of biopharma R&D and more... |
| 2015-11-11 00:15 | | Sophiris' prostate drug stages a Phase III comeback after a grim prognosis and more... |
| 2015-11-10 12:15 | | Big Pharma's Shoes Don't Fit Amgen and more... |
| 2015-11-10 00:15 | | AbbVie Humira Patent Loss To Be Biggest Ever In History and more... |
| 2015-11-09 12:15 | | Cytokinetics, Amgen drug shows promise in heart failure study and more... |
| 2015-11-08 12:15 | | Is Celgene's Otezla Coming of Age? and more... |
| 2015-11-08 00:15 | | Vertex Pharmaceuticals' $2.6 Billion Bet on CRISPR and more... |
| 2015-11-07 12:15 | | 5 BioPharma Movers That Cannot Be Ignored and more... |
| 2015-11-07 00:15 | | Why Valeant Pharmaceuticals (VRX) Could Be Acquired By Pfizer and more... |
| 2015-11-06 12:15 | | AstraZeneca agrees to buy ZS Pharma for $2.7 billion and more... |
| 2015-11-06 00:15 | | Gilead, AbbVie Asked by U.S. for Hepatitis C Pricing Options and more... |
| 2015-11-05 12:15 | | Celgene Corporation (CELG) Nearly 4% Down On Better Q3 EPS, Lower-Than-Expected Revenue and more... |
| 2015-11-05 00:15 | | What to Expect From Celgene Earnings and more... |
| 2015-11-04 12:15 | | U.S. Senate panel probing Valeant, Turing over drug costs and more... |
| 2015-11-04 00:15 | | Bristol-Myers Leads the Pack in Immuno-Oncology; Credit Suisse Sees $10.5B in 2020 Sales and more... |
| 2015-11-03 12:15 | | GSK boss silent on report drugmaker rebuffed Pfizer and more... |
| 2015-11-03 00:15 | | Will a compounded version of Martin Shkreli’s drug really make a difference? and more... |
| 2015-11-02 12:15 | | Activist investor Ackman holds marathon call defending embattled Valeant and more... |
| 2015-11-01 12:15 | | What Do Analysts Recommend for Biogen Prior to 3Q15 Earnings? and more... |
